CJC-1295 with DAC.

Quick Overview.

CJC-1295 (With DAC) is a synthetic growth hormone-releasing hormone (GHRH) analogue designed to stimulate the pituitary gland to release growth hormone (GH). The addition of the Drug Affinity Complex (DAC) allows the peptide to bind to serum albumin [1], significantly extending its half-life to approximately 6-8 days. This results in a continuous, non-pulsatile elevation of GH and IGF-1 levels [2], rather than the natural pulsatile release seen with other secretagogues.

• Primary Use Case: Sustained elevation of GH and IGF-1 for recovery, anti-aging, and muscle preservation.
• Mechanism: Binds to the GHRH receptor on the pituitary gland, stimulating GH release. The DAC modification prevents rapid enzymatic degradation.
• Who it is for: Advanced researchers seeking continuous GH elevation without the need for multiple daily injections.
• Who it is NOT for: Beginners, tested athletes, or those seeking to mimic natural physiological GH pulses.

The Protocol & Usage Guide.

Before You Start

• Baseline Bloodwork: IGF-1, fasting glucose, HbA1c, prolactin, and a full thyroid panel.
• Supplies: Insulin syringes (29-31G, 0.5-1cc), bacteriostatic water, alcohol swabs.
• Storage: Refrigerate reconstituted peptide immediately.

Standard Dosing

Note: Dosing claims are based on community consensus community and limited clinical data emerging.

Reconstitution Math (Example: 2mg vial)

• Add 2mL of bacteriostatic water to a 2mg vial.
• 1,000 mcg (1 mg) = 100 units (1.0 mL) on an insulin syringe.
• 500 mcg = 50 units (0.5 mL).

Cycle Length

• Typical Cycle: 12-16 weeks.
• Washout: 4-8 weeks off to allow pituitary resensitization.

Missed Dose Protocol

If a weekly dose is missed, administer it as soon as remembered, provided the next scheduled dose is at least 3 days away. If closer, skip the missed dose and resume the normal schedule.

Nutritional Support & Recommended Supplements.

• Zinc and Magnesium: Essential for natural GH production and sleep quality. (Zinc: 15-30mg/day; Magnesium: 200-400mg/day).
• Vitamin D3: Supports bone health and immune function, which are upregulated by GH. (2,000-5,000 IU/day).
• Berberine or Metformin: To manage potential insulin resistance caused by sustained GH elevation. (Berberine: 500mg 2-3x/day with meals).

Safety, Interactions & Side Effect Management.

Side Effects

Contraindications

• Absolute: Active malignancy (GH/IGF-1 can promote tumor growth), severe diabetic retinopathy.
• Relative: Pre-existing insulin resistance or Type 2 Diabetes.

Red Flags

Discontinue use and consult a physician if you experience:

• Fasting blood glucose consistently >100 mg/dL.
• Severe joint pain or carpal tunnel syndrome symptoms.
• Unexplained visual changes.

Pregnancy, Lactation & Fertility

No data available. Use is strictly contraindicated.

Common Stacks & Combinations.

Synergistic Stacks

• CJC-1295 (With DAC) + GHRP-2 or GHRP-6: While less common than stacking with No DAC, some users combine it with a GHRP to maximize the GH pulse on top of the elevated baseline. community

Anti-Pattern Stacks (Avoid)

Body Composition & Training Guide.

Expected Trajectory

Contexts

• Bulking: Supports recovery and nutrient partitioning, though water retention can mask true muscle gain.
• Cutting: Aids in fat mobilization and muscle preservation during a caloric deficit.

Storage, Handling & Accessibility.

• Unreconstituted (Lyophilized Powder): Store in the freezer (-20°C) for up to 24 months.
• Reconstituted: Store in the refrigerator (2-8°C). Use within 14-21 days.
• Sourcing: Widely available through research chemical vendors. Not approved for human use.

Bloodwork Monitoring Guide.

Baseline (Before starting)

• IGF-1, Fasting Glucose, HbA1c, Prolactin, Comprehensive Metabolic Panel (CMP).

Mid-Cycle (Week 6-8)

• IGF-1 (to confirm efficacy), Fasting Glucose/HbA1c (to monitor insulin sensitivity).

Post-Cycle (4 weeks after cessation)

• IGF-1, Fasting Glucose, HbA1c.

Doctor Handoff Note: If presenting to a physician, explain that you are using a long-acting GHRH analogue that continuously elevates GH and IGF-1, which may impact glucose metabolism.

Comparison to Similar Compounds.

Deep Dive (For Advanced Researchers).

Mechanism of Action

CJC-1295 is a synthetic analogue of endogenous GHRH (1-29). The addition of the Drug Affinity Complex (DAC)—a maleimido group at the C-terminus—allows the peptide to covalently bind to endogenous serum albumin after injection. This bioconjugation protects the peptide from rapid enzymatic degradation by dipeptidyl peptidase IV (DPP-IV), extending its half-life from minutes to over a week. well-established [1] [2]

This extended half-life results in a continuous, non-pulsatile stimulation of the pituitary gland, leading to sustained elevations in both GH and IGF-1 levels. While effective for increasing total GH output, this non-physiological release pattern raises concerns about pituitary exhaustion and insulin resistance over long-term use. emerging [3]

Trial Data

Active Metabolites

No data available.

Open Questions

• Does the continuous, non-pulsatile stimulation of the pituitary gland by CJC-1295 (With DAC) lead to long-term receptor downregulation or pituitary exhaustion?
• What is the precise impact of sustained GH elevation on insulin sensitivity compared to pulsatile secretagogues?
• Anti-doping detection methods for CJC-1295 in equine plasma[7] and human biological samples[8] have been validated.

Frequently Asked Questions (FAQ).

Q: What is the difference between CJC-1295 With DAC and No DAC? A: The DAC (Drug Affinity Complex) extends the half-life of the peptide to 6-8 days, resulting in continuous GH release. "No DAC" (Mod GRF 1-29) has a half-life of ~30 minutes and causes a natural, pulsatile GH release.

Q: How often should I inject CJC-1295 With DAC? A: Due to its long half-life, it is typically injected once or twice a week.

Q: Will CJC-1295 With DAC cause water retention? A: Yes, water retention is a common side effect due to the sustained elevation of GH.

Q: Do I need to stack it with an Ipamorelin or GHRP? A: It is not strictly necessary. While some users stack it to add a pulse on top of the elevated baseline, it is effective on its own.

Q: Can women use CJC-1295 With DAC? A: Yes, but women should be aware of the potential for water retention and monitor for any changes in menstrual cycles.

Q: Is CJC-1295 With DAC legal in sports? A: No. It is a prohibited substance under WADA regulations.

Q: Does it cause insulin resistance? A: Sustained elevation of GH can decrease insulin sensitivity. Monitoring fasting blood glucose is highly recommended.

Regulatory & Anti-Doping Status.

• WADA Status: Prohibited at all times (Section S2: Peptide Hormones, Growth Factors, Related Substances, and Mimetics).[5] Validated detection methods exist for both equine[7] and human samples.[8]
• US FDA: Not approved for human use.
• UK MHRA: Unlicensed medicine.
• EU EMA: Not approved.
• Health Canada: Not approved.
• Australia TGA: Schedule 4 (Prescription Only Medicine) or Schedule 10 (Substances of such danger to health as to warrant prohibition of sale, supply and use) depending on specific classification.

Decision Tree.

Is your primary goal sustained, continuous elevation of GH and IGF-1?
├── NO: Consider a pulsatile secretagogue like Ipamorelin or CJC-1295 (No DAC).
└── YES: Are you a tested athlete?
    ├── YES: STOP. CJC-1295 is banned by WADA ^[3].
    └── NO: Are you concerned about potential insulin resistance or water retention?
        ├── YES: Consider a shorter-acting secretagogue to mimic natural physiology.
        └── NO: CJC-1295 (With DAC) may be appropriate. Monitor blood glucose closely.

Schema.org Data.

{
  "@context": "https://schema.org",
  "@type": "MedicalEntity",
  "name": "CJC-1295 (With DAC)",
  "description": "A synthetic growth hormone-releasing hormone (GHRH) analogue with a Drug Affinity Complex (DAC) that extends its half-life, causing sustained elevation of GH and IGF-1.",
  "legalStatus": "Not approved for human use; WADA prohibited."
}

{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the difference between CJC-1295 With DAC and No DAC?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The DAC (Drug Affinity Complex) extends the half-life of the peptide to 6-8 days, resulting in continuous GH release. 'No DAC' (Mod GRF 1-29) has a half-life of ~30 minutes and causes a natural, pulsatile GH release."
      }
    },
    {
      "@type": "Question",
      "name": "How often should I inject CJC-1295 With DAC?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Due to its long half-life, it is typically injected once or twice a week."
      }
    },
    {
      "@type": "Question",
      "name": "Will CJC-1295 With DAC cause water retention?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, water retention is a common side effect due to the sustained elevation of GH."
      }
    },
    {
      "@type": "Question",
      "name": "Do I need to stack it with an Ipamorelin or GHRP?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "It is not strictly necessary. While some users stack it to add a pulse on top of the elevated baseline, it is effective on its own."
      }
    },
    {
      "@type": "Question",
      "name": "Can women use CJC-1295 With DAC?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, but women should be aware of the potential for water retention and monitor for any changes in menstrual cycles."
      }
    },
    {
      "@type": "Question",
      "name": "Is CJC-1295 With DAC legal in sports?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "No. It is a prohibited substance under WADA regulations."
      }
    },
    {
      "@type": "Question",
      "name": "Does it cause insulin resistance?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Sustained elevation of GH can decrease insulin sensitivity. Monitoring fasting blood glucose is highly recommended."
      }
    }
  ]
}

What we cited.